Genmab Launches Cash Tender Offer for Merus Common Shares at $97.00 per Share

Genmab is commencing a cash tender offer for all outstanding common shares of Merus N.V. at $97.00 per share. The offer is being made pursuant to a transaction agreement and is subject to certain conditions. Merus shareholders should read the tender offer documents before making a decision on whether to tender their shares. The offer will expire on December 11, 2025, or be extended if certain conditions are met.